Guided Therapeutics Inc (GTHP)

0.00
OTC : Health Care
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 6.50
Avg Volume 9.01M
Exchange OTC
Shares Outstanding 153.92M
EPS -15.80
Div & Yield N.A. (N.A)

Latest News

Guided Therapeutics Ships Additional LuViva® Advanced Cervical Scan Systems And Disposables To Bangladesh

Guided Therapeutics Ships Additional LuViva® Advanced Cervical Scan Systems And Disposables To Bangladesh

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it shipped four additional LuViva® Advanced Cervical Scan...

Guided Therapeutics Sells First LuViva® Advanced Cervical Scan To Russia

Guided Therapeutics Sells First LuViva® Advanced Cervical Scan To Russia

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has sold the first LuViva® Advanced Cervical Scan to its...

Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has shipped five LuViva® Advanced Cervical Scans to...

Guided Therapeutics Expanding Use Of The LuViva® Advanced Cervical Scan In Bulgaria

Guided Therapeutics Expanding Use Of The LuViva® Advanced Cervical Scan In Bulgaria

Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has received an order and payment for a third LuViva® Advanced Cervical Scan and 500 single-use disposable cervical guides for Bulgaria.

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan License Agreement For China

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan License Agreement For China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached a licensing agreement with Shenghuo Medical, LLC,...

Guided Therapeutics Reports Record First Quarter 2016 Results

Guided Therapeutics Reports Record First Quarter 2016 Results

Guided Therapeutics, Inc. (OTCQB:GTHP) today announced its operating results for the first quarter ended March 31, 2016.

Guided Therapeutics Ships First LuViva® Advanced Cervical Scan For The Dominican Republic

Guided Therapeutics Ships First LuViva® Advanced Cervical Scan For The Dominican Republic

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today shipment of the first LuViva ® Advanced Cervical Scan for the...

Guided Therapeutics Issues Letter To Shareholders

Guided Therapeutics Issues Letter To Shareholders

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today released the following letter to shareholders.

Guided Therapeutics Announces 1:100 Reverse Stock Split

Guided Therapeutics Announces 1:100 Reverse Stock Split

Guided Therapeutics, Inc. (OTCQB: GTHP) today announced a one-for-one hundred (1:100) reverse split of its issued and outstanding common stock.

Guided Therapeutics Expands LuViva® Advanced Cervical Scan Distribution In Latin America

Guided Therapeutics Expands LuViva® Advanced Cervical Scan Distribution In Latin America

Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company continues to expand in international markets with the...

Guided Therapeutics' To Sell Five Additional LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics' To Sell Five Additional LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics, Inc. (OTCQB: GTHP), a maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that Nairobi County Health Services Sector has agreed to purchase an...

Guided Therapeutics Expects Significant Sales Growth In 2016

Guided Therapeutics Expects Significant Sales Growth In 2016

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company expects to achieve a second consecutive quarter of...

Guided Therapeutics Achieves Record Quarterly Revenue

Guided Therapeutics Achieves Record Quarterly Revenue

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical...

Guided Therapeutics Ships First Order Of 10,000 LuViva® Advanced Cervical Scan Disposables For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics Ships First Order Of 10,000 LuViva® Advanced Cervical Scan Disposables For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it shipped the first 10,000 LuViva® Advanced Cervical Scan...

Guided Therapeutics And FDA Review Team Agree On Path Forward For LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics And FDA Review Team Agree On Path Forward For LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today it believes it has reached a general agreement with the U.

Guided Therapeutics To Present At LD Micro

Guided Therapeutics To Present At LD Micro "Main Event" Investor Conference

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will be presenting at the LD Micro "Main Event" Investor...

Guided Therapeutics Reports Third Quarter 2015 Financial Results

Guided Therapeutics Reports Third Quarter 2015 Financial Results

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it reported third quarter financial results for the period ended...

Guided Therapeutics Schedules Conference Call To Discuss Third Quarter 2015 Financial Results

Guided Therapeutics Schedules Conference Call To Discuss Third Quarter 2015 Financial Results

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will report its 2015 third quarter financial results...

FDA Grants Guided Therapeutics' Request For New Meeting Date To Plan Path Forward For LuViva® Advanced Cervical Scan PMA Application

FDA Grants Guided Therapeutics' Request For New Meeting Date To Plan Path Forward For LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today the U.

2016 Turkish Ministry Of Health Order For Guided Therapeutics' LuViva® Advanced Cervical Scan Four Times 2015 Projected Revenue

2016 Turkish Ministry Of Health Order For Guided Therapeutics' LuViva® Advanced Cervical Scan Four Times 2015 Projected Revenue

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that contracted revenue from its 2016 Turkish Ministry of Health...

Guided Therapeutics Expands China Rights Negotiations For LuViva® Advanced Cervical Scan To Three Potential Partners

Guided Therapeutics Expands China Rights Negotiations For LuViva® Advanced Cervical Scan To Three Potential Partners

Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it is now negotiating with three groups for rights to sell LuViva...

Guided Therapeutics' Fourth Quarter Orders Of LuViva® Advanced Cervical Scan Disposables Triple 2014 Total Sales

Guided Therapeutics' Fourth Quarter Orders Of LuViva® Advanced Cervical Scan Disposables Triple 2014 Total Sales

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it expects to ship 25 LuViva® Advance Cervical Scan units...

Study Finds Guided Therapeutics' LuViva® Advanced Cervical Scan Can Predict Future Worsening Of Precancer

Study Finds Guided Therapeutics' LuViva® Advanced Cervical Scan Can Predict Future Worsening Of Precancer

Results of a study presented at a major international women's health conference indicate that the LuViva® Advanced Cervical Scan was able predict which women would progress from mild cervical abnormalities to more...

Guided Therapeutics Ships First Four LuViva® Advanced Cervical Scans For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics Ships First Four LuViva® Advanced Cervical Scans For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has shipped the first four LuViva® Advance Cervical Scan...

Guided Therapeutics To Present At 2015 Aegis Growth Conference

Guided Therapeutics To Present At 2015 Aegis Growth Conference

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid, point of care cervical cancer testing platform based on its patented biophotonic technology, announced today that it will be presenting at the 2015 Aegis Growth...

Guided Therapeutics And U.S. FDA Agree On Meeting Date To Plan Path Forward For LuViva® Advanced Cervical Scan Premarket Approval Application

Guided Therapeutics And U.S. FDA Agree On Meeting Date To Plan Path Forward For LuViva® Advanced Cervical Scan Premarket Approval Application

Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today it will meet with the U.

Guided Therapeutics' Turkish Distributor Doubles Order For LuViva® Advanced Cervical Scan Single-Use Disposables For Turkish Ministry Of Health

Guided Therapeutics' Turkish Distributor Doubles Order For LuViva® Advanced Cervical Scan Single-Use Disposables For Turkish Ministry Of Health

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that its Turkish distributor, ITEM Medical Technologies, has received...

From Our Partners